SRDX (Surmodics) Cyclically Adjusted FCF per Share: $0.45 (As of Jun. 2025)


SRDX Surmodics Inc SRDX
51 GF Score
Price $42.98
View Full Analysis

What is Surmodics Cyclically Adjusted FCF per Share?

Surmodics SRDX -0.01% 51 Cyclically Adjusted FCF per Share is $0.45 as of Jun. 2025. GuruFocus rates SRDX with a GF Score™ of 51/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Surmodics's adjusted free cash flow per share for the three months ended in Jun. 2025 was $0.063. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.45 for the trailing ten years ended in Jun. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-06), Surmodics's current stock price is $42.98. Surmodics's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2025 was $0.45. Surmodics's Cyclically Adjusted Price-to-FCF of today is 95.51.


Surmodics  (NAS:SRDX) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Surmodics's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=42.98/0.45
=95.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Surmodics Cyclically Adjusted FCF per Share Related Terms


Surmodics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Surmodics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surmodics Cyclically Adjusted FCF per Share Chart

Surmodics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.01 1.01 0.82 0.76 0.60

Surmodics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.60 0.49 0.49 0.45

SRDX vs CBLL, OFIX, LAB: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Surmodics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surmodics Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Surmodics's Cyclically Adjusted Price-to-FCF falls into.


SRDX
51GF Score
Surmodics Inc SRDX
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Surmodics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Surmodics's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2025 (Change)*Current CPI (Jun. 2025)
=0.063/322.5610*322.5610
=0.063

Current CPI (Jun. 2025) = 322.5610.

Surmodics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201509 0.114 237.945 0.155
201512 0.447 236.525 0.610
201603 0.205 238.132 0.278
201606 0.384 241.018 0.514
201609 0.247 241.428 0.330
201612 0.030 241.432 0.040
201703 0.074 243.801 0.098
201706 0.103 244.955 0.136
201709 0.363 246.819 0.474
201712 -0.052 246.524 -0.068
201803 1.789 249.554 2.312
201806 -0.424 251.989 -0.543
201809 0.162 252.439 0.207
201812 -0.540 251.233 -0.693
201903 0.030 254.202 0.038
201906 -0.114 256.143 -0.144
201909 0.719 256.759 0.903
201912 -0.187 256.974 -0.235
202003 0.111 258.115 0.139
202006 0.807 257.797 1.010
202009 0.019 260.280 0.024
202012 -0.482 260.474 -0.597
202103 1.099 264.877 1.338
202106 0.134 271.696 0.159
202109 -0.108 274.310 -0.127
202112 -0.563 278.802 -0.651
202203 -0.385 287.504 -0.432
202206 -0.313 296.311 -0.341
202209 -0.220 296.808 -0.239
202212 -0.842 296.797 -0.915
202303 -0.467 301.836 -0.499
202306 1.806 305.109 1.909
202309 0.036 307.789 0.038
202312 -0.675 306.746 -0.710
202403 0.433 312.332 0.447
202406 -0.211 314.175 -0.217
202409 0.220 315.301 0.225
202412 -0.576 315.605 -0.589
202503 0.044 319.799 0.044
202506 0.063 322.561 0.063

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.45 mean?
Surmodics (SRDX) has a Cyclically Adjusted FCF per Share of $0.45 as of Jun. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Surmodics and its competitors.
Is Surmodics' Cyclically Adjusted FCF per Share too high?
Surmodics' current Cyclically Adjusted FCF per Share is $0.45. Overall, Surmodics has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Surmodics' Cyclically Adjusted FCF per Share compare to CBLL and OFIX?
Surmodics' Cyclically Adjusted FCF per Share of $0.45 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Surmodics and its competitors. Surmodics's current Cyclically Adjusted FCF per Share is $0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surmodics stock overvalued right now?
Surmodics (SRDX) has a current Cyclically Adjusted FCF per Share of $0.45. The current Cyclically Adjusted FCF per Share is $0.45. Surmodics' overall GF Score™ is 51/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Surmodics (SRDX), the current Cyclically Adjusted FCF per Share is $0.45 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Surmodics Business Description

Address 9924 West 74th Street, Eden Prairie, MN, USA, 55344
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
51GF Score

Get the complete analysis for SRDX

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$42.98
Price